ICARS Strategy 2022 -2026

  29 August 2022

Since its inception in spring 2019, ICARS has bolted out of the starting blocks and achieved a great deal in its first years. These achievements were based on the strong strategic pillars that were developed in the early days to address the clear need, expressed by low- and middle-income countries, for tailored solutions to support National Action Plan implementation.

In this, our first official strategy, we draw on the lessons we have learnt, and project ourselves into the future. Guided by our vision of a world without drug-resistant infections, we have revised our outcome framework and refined the scope and goals of each of our interconnected pillars. In the following we are pleased to present a succinct overview of ICARS unique value proposition, followed by our overarching strategy that will run until 2026, as well as a roadmap that details our planned activities per pillar.

Download ICARS strategy to view on screen.

Further reading: ICARS
Author(s): ICARS
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!